Quantum Computing Inc. (QUBT): M&A transaction — Quantum Computing Inc. completes $110M acquisition of Luminar Semiconductor from Luminar Technologies

Quantum Computing Inc.

Quantum Computing Inc. acquired all outstanding shares of Luminar Semiconductor, Inc. for $110 million in cash, closed on February 2, 2026.
This amendment provides audited financial statements of Luminar Semiconductor for years ended December 31, 2025 and 2024.
Luminar Semiconductor reported net loss of $11.8 million for 2025 and accumulated deficit of $106.2 million as of December 31, 2025.
Purchase consideration included $97.5 million cash at closing plus $11.0 million held in escrow for indemnification until February 2027.
Luminar Semiconductor's revenue was $29.8 million in 2025, down from $32.5 million in 2024; gross profit declined from $8.6M to $3.5M.

Key facts

Extracted from this filing and checked against the source text.

M&A Transactions SEC 8-K Item 2.01/5.01 confidence 0.9

Quantum Computing Inc. completed an acquisition involving Luminar Technologies, Inc. for $110.0 million in cash (closed 2026-02-02).

Action: acquisition
Counterparty: Luminar Technologies, Inc.
Consideration: $110.0 million in cash
Closing: 2026-02-02

Exact text from the filing

and outstanding shares of common stock of LSI from the Seller (the “Acquisition”). The Transaction was completed on February 2, 2026 (the “Closing Date”). The purchase price was $110.0 million in cash, subject to a dollar-for-dollar adjustment to the extent that the working capital at closing is greater or less than the target working capital of $8.1 million. The

View on SEC.gov

Browse all m&a transactions →

Quantum Computing Inc. filing history →

Source: SEC EDGAR

accession 0001213900-26-045225

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.